Curon Medical, Inc. to Present at the Healthcare Robins Roadshow.Business Editors FREEMONT, Calif.--(BUSINESS WIRE)--June 7, 2004 Curon Medical, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CURN), will be presenting at the Healthcare Robins Roadshow Equity Conference. June 10, 2004, at 2:30 p.m. Eastern Time This conference presentation is being webcast by Thomson/CCBN and can be accessed at the following URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. address: www.robinsmediagroup.com/healthcare The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com). Curon Medical, Inc. develops, manufactures and markets products for the treatment of gastrointestinal disorders. Its first product, the Stretta stret·ta n. pl. stret·te or stret·tas See stretto. [Italian, feminine of stretto, stretto; see stretto.] (R) System, received United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) clearance in April 2000 for the treatment of gastroesophageal reflux disease gastroesophageal reflux disease (GERD) Disorder characterized by frequent passage of gastric contents from the stomach back into the esophagus. Symptoms of GERD may include heartburn, coughing, frequent clearing of the throat, and difficulty in swallowing. (GERD GERD gastroesophageal reflux disease. GERD abbr. gastroesophageal reflux disease GERD ). The Company commercially launched the Stretta System in May 2000. As of March 31, 2004, Curon had sold 296 control modules worldwide, and approximately 6,000 patients have been treated with the Stretta procedure. Its second product, the Secca(R) System, is a radio frequency (RF) energy-based system for treatment of fecal incontinence. In March 2002, the Company received 510(k) clearance from the FDA to market the Secca System for the treatment of fecal incontinence in patients who have failed more conservative therapies, such as diet modification and biofeedback. The conference will be moderated by Marc Robins, CFA, the founder of Catalyst Financial Resources and founder of The Red Chip Review. Marc has 25 years of experience in capital markets. Experience which includes a regularly featured column in Forbes, contributed articles in the AAII AAII See: American Association of Individual Investors Journal and his frequent quotes found in various financial media. The conference is part of a series of Robins Roadshows provided by Robins Media Group and Catalyst Financial Resources. These Roadshows place small-cap companies before a professional audience of buy-side, sell-side analysts, portfolio managers, research directors, and chief investment officers whose investment styles are relative to the profiles of the presenting companies. Also appearing and delivering the keynote address will be Blair Childs, Executive Vice President of Strategic Planning and Implementation for AdvaMed. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion